Summary
A 45-year-old information systems analyst for a defense contractor was denied renewal of his security clearance under Guideline H (Drug Involvement). The applicant had been granted a security clearance in 2008 but subsequently used marijuana from March 2011 until at least April 2013.
The applicant's marijuana use was for both medicinal and recreational purposes, and while legally prescribed in his state, it remains illegal under federal law. Disqualifying conditions cited included AG ¶ 24, AG ¶ 25(a), AG ¶ 25(c), AG ¶ 25(g), and AG ¶ 25(h).
The denial was based on the applicant's continued marijuana use while holding a security clearance and his expressed intent to continue using it despite its federal illegality. The applicant did not present mitigating evidence to address the security concerns raised by his drug involvement.
Why the Applicant Was Denied
- Applicant used marijuana for medicinal and recreational purposes while holding a security clearance.
- Applicant expressed intent to continue using marijuana despite its illegality under federal law.
- Applicant did not present mitigating evidence to address the security concerns raised by his drug use.
Conditions Referenced
- AG ¶ 24raisedDrug Involvement
- AG ¶ 25(a)appliedAny Drug Abuse
- AG ¶ 25(c)appliedIllegal Drug Possession
- AG ¶ 25(g)appliedIllegal Drug Use After Being Granted a Security Clearance
- AG ¶ 25(h)appliedExpressed Intent to Continue Illegal Drug Use
Key Rule Quoted
“A security clearance decision is intended only to resolve whether it is clearly consistent with the national interest for an applicant to either receive or continue to have access to classified information.”
Procedural Posture
- SOR issuedMar 23, 2015
- Answer filedNot specifiedApplicant requested a decision without a hearing.
- Hearing heldNot applicableDecision made without a hearing.
- Decision dateMay 31, 2016
Cite For
- Impact of Federal Law on State-legal Marijuana Use Under Guideline H
- Security Concerns Related to Drug Involvement While Holding a Security Clearance
- The Necessity of Mitigating Evidence in Drug-related Clearance Cases